Neupulse

Neupulse is a UK-based medical technology company dedicated to developing non-invasive, wearable solutions for individuals with Tourette Syndrome. Their flagship product is a wrist-worn device that delivers gentle electrical stimulation to the median nerve, aiming to reduce tics and the urge to tic. Founded by researchers from the University of Nottingham, Neupulse is built on a foundation of extensive research into brain network function and the potential of non-invasive brain stimulation techniques. They have received significant funding, including investment from the Midlands Engine Investment Fund II, and have a strong track record of clinical trials demonstrating the efficacy of their approach.

Neupulse collaborates closely with Tourettes Action, a leading UK charity, and prioritizes patient feedback in shaping their product development. Their commitment to improving the lives of individuals with Tourette Syndrome is evident in their research, their partnerships, and their ongoing efforts to bring their innovative device to market. This, combined with their dedication to achieving regulatory approvals, positions Neupulse as a promising player in the field of Tourette Syndrome treatment.

Neupulse is a company dedicated to improving the lives of individuals with Tourette Syndrome by developing a safe and effective non-drug treatment for tic disorders. Their research focuses on using non-invasive brain stimulation techniques, specifically median nerve stimulation, to modulate brain network function and reduce the frequency and severity of tics. They are currently developing a wearable wrist device that delivers this stimulation, aiming to empower individuals with Tourette Syndrome to manage their symptoms and have control over their tics.

Neupulse promotes a culture focused on innovation and collaboration, driven by a strong commitment to improving the lives of people with Tourette Syndrome. The company fosters a supportive and inclusive environment, actively engaging with individuals with Tourette's and their families to understand their needs and prioritize their well-being. This dedication extends to their team, valuing their contributions and celebrating their achievements through recognition programs and events.

Neupulse demonstrates a commitment to diversity, equity, and inclusion through its focus on improving the lives of people with Tourette Syndrome. The company's team has completed training with Tourettes Action, ensuring an understanding of the condition and fostering a welcoming environment for employees and those they serve. This commitment is further evidenced by their partnerships with organizations like Tourettes Action and their participation in the Move for Tourette's challenge. By actively engaging with the Tourette's community and promoting awareness, Neupulse fosters a culture of inclusivity and empathy.